Skip to main content
Premium Trial:

Request an Annual Quote

ChemAxon, Patcore Ink Software Distribution Agreement

Premium

ChemAxon said this week that it has signed an agreement with Patcore that allows it to distribute the Japanese cheminformatics software company's applications globally.

Patcore produces and markets the CRAIS product series — a suite of cheminformatics applications based on ChemAxon's toolkits that cover many research processes such as compound registration, assay management, data browsing, collaborative interfaces, structure design, and controlled substance compliance.

The suite is comprised of Checker, a controlled substances check system; Transformer, which is used to generate ideas for lead optimization; Browser, used for exploring chemical and biological data; a tool for compound registration; and Assay, which is a standardized environment for registering assay results.

The financial details of the agreement were not disclosed.

The Scan

RNA Editing in Octopuses Seems to Help Acclimation to Shifts in Water Temperature

A paper in Cell reports that octopuses use RNA editing to help them adjust to different water temperatures.

Topical Compound to Block EGFR Inhibitors May Ease Skin Toxicities, Study Finds

A topical treatment described in Science Translational Medicine may limit skin toxicities seen with EGFR inhibitor therapy.

Dozen Genetic Loci Linked to Preeclampsia Risk in New GWAS

An analysis of genome-wide association study data in JAMA Cardiology finds genetic loci linked to preeclampsia that have ties to blood pressure.

Cancer Survival Linked to Mutational Burden in Pan-Cancer Analysis

A pan-cancer paper appearing in JCO Precision Oncology suggests tumor mutation patterns provide clues for predicting cancer survival that are independent of other prognostic factors.